GENEACUITY Trademark

Trademark Overview


On Tuesday, June 4, 2024, a trademark application was filed for GENEACUITY with the United States Patent and Trademark Office. The USPTO has given the GENEACUITY trademark a serial number of 98585039. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, April 3, 2025. This trademark is owned by GeneAcuity LLC. The GENEACUITY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SaaS) services featuring software for evaluating and reporting results of genetic and biomarker testing; Platform as a service (PAAS) featuring computer software for use in the collection, recording, analysis, evaluation, reporting and processing of genetic test kit results; Software as a service (SaaS) services featuring software for use in the design, development and deployment of genetic testing kits and recovery and collection of results generated therefrom; Software as a service (SAAS) services featuring software for commercial analysis, data aggregation, information reporting; Software as a service (SAAS) services, namely, hosting software for use by others for use in data aggregation and information reporting; Providing temporary use of a web-based software application for data aggregation, and information reporting; Consulting in the field of product design and development of genetic testing kits; Consulting in the field of proper use of and interpretatio...
geneacuity

General Information


Serial Number98585039
Word MarkGENEACUITY
Filing DateTuesday, June 4, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, April 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSoftware as a service (SaaS) services featuring software for evaluating and reporting results of genetic and biomarker testing; Platform as a service (PAAS) featuring computer software for use in the collection, recording, analysis, evaluation, reporting and processing of genetic test kit results; Software as a service (SaaS) services featuring software for use in the design, development and deployment of genetic testing kits and recovery and collection of results generated therefrom; Software as a service (SAAS) services featuring software for commercial analysis, data aggregation, information reporting; Software as a service (SAAS) services, namely, hosting software for use by others for use in data aggregation and information reporting; Providing temporary use of a web-based software application for data aggregation, and information reporting; Consulting in the field of product design and development of genetic testing kits; Consulting in the field of proper use of and interpretation of genetic testing kits for scientific research purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 4, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGeneAcuity LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78750

Trademark Events


Event DateEvent Description
Wednesday, June 5, 2024NEW APPLICATION ENTERED
Monday, December 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2024ASSIGNED TO EXAMINER
Friday, January 3, 2025NON-FINAL ACTION E-MAILED
Friday, January 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 3, 2025NON-FINAL ACTION WRITTEN
Thursday, April 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED